0 24 OK J-STAGE3GLP-1 GLP-1 J-STAGE1GLP-1 3 GLP-1 GLP-1 GLP-1 GLP-1(-1) GLP-1 GLP-1 PMDA2.5mg5mg7.5mg10mg12.5mg15mg PMDA2mg PMDA3mg7mg14mg GLP-1 GLP-1 GLP-1 GLP-1 GLP-1GIP/GLP-1 () GLP-1 GLP-1 GLP-1 GLP-1 e- GLP-1 GLP-1 GLP-1 GIP/GLP-1()GLP-1()SGLT2() LINE 0 24 OK DMM DMM 200 24365 GLP-1 DMM OK PC ()() 1,000OFF GLP-1GIP/GLP-1 1()()() 22,000(2.5mg 4) 5,200/(3mg 11) GLP-1GIP/GLP-1SGLT2 GLP-1GIP/GLP-1 PC GLP-1GLP-1 0 24 OK
Combining the two does not create new drug interactions, but gastrointestinal side effects may compound, requiring careful dose titration and patient monitoring
For Energy & Metabolism: 1,000mg2,000mg per day can support mitochondrial function, reducing fatigue and enhancing endurance
doi:10.1016/S0888-7543(05)80373-8
however, it has distinct features of progressive immune-mediated neuro-inflammatory evens resulting in multiple demyelinating lesions ( It is recognized that immune cells play a major pathological role in MS
